[
  {
    "title": "FDC-Logic-001",
    "summary": "Hybrid peptide coordination structure designed to suppress oxidative stress in inflamed tissue environments.",
    "submitted_by": "Dr. E. Okeke, NovaPharma",
    "approved_on": "2025-04-08"
  },
  {
    "title": "FDC-Logic-002",
    "summary": "RNA-ligand hybrid architecture leveraging co-regulated delivery of immune modifiers.",
    "submitted_by": "SynBioLabs, Tier 1 Participant",
    "approved_on": "2025-04-11"
  },
  {
    "title": "FDC-Logic-003",
    "summary": "Programmable FDC with switchable kinase inhibition states under metal-flux conditions.",
    "submitted_by": "KT Biotech Internal Simulation",
    "approved_on": "2025-04-12"
  }
]
